Clinical Trials Browser

Phase 2 × Not yet recruiting × telisotuzumab vedotin × Clear all

NCT07323641 2026-01-07

Telisotuzumab Vedotin and Osimertinib for the Treatment of Progressive, Incurable, Non Small Cell Lung Cancer

Phase 2 Not yet recruiting

Carcinoma, Non-Small-Cell Lung